AAAAAA

   
Results: 1-20 |
Results: 20
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency
Authors: Pal, R Venzon, D Letvin, NL Santra, S Montefiori, DC Miller, NR Tryniszewska, E Lewis, MG VanCott, TC Hirsch, V Woodward, R Gibson, A Grace, M Dobratz, E Markham, PD Hel, Z Nacsa, J Klein, M Tartaglia, J Franchini, G
Citation: R. Pal et al., ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency, J VIROLOGY, 76(1), 2002, pp. 292-302
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection
Authors: Kim, JH Mascola, JR Ratto-Kim, S VanCott, TC Loomis-Price, L Cox, JH Michael, NL Jagodzinski, L Hawkes, C Mayers, D Gilliam, BL Birx, DC Robb, ML
Citation: Jh. Kim et al., Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection, AIDS RES H, 17(11), 2001, pp. 1021-1034
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
Authors: Mascola, JR Stiegler, G VanCott, TC Katinger, H Carpenter, CB Hanson, CE Beary, H Hayes, D Frankel, SS Birx, DL Lewis, MG
Citation: Jr. Mascola et al., Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies, NAT MED, 6(2), 2000, pp. 207-210
Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins
Authors: Gorny, MK VanCott, TC Williams, C Revesz, K Zolla-Pazner, S
Citation: Mk. Gorny et al., Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins, VIROLOGY, 267(2), 2000, pp. 220-228
Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants
Authors: Kim, JJ Yang, JS VanCott, TC Lee, DJ Manson, KH Wyand, MS Boyer, JD Ugen, KE Weiner, DB
Citation: Jj. Kim et al., Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants, J VIROLOGY, 74(7), 2000, pp. 3427-3429
Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand
Authors: Chuachoowong, R Shaffer, N VanCott, TC Chaisilwattana, P Siriwasin, W Waranawat, N Vanprapar, N Young, NL Mastro, TD Lambert, JS Robb, ML
Citation: R. Chuachoowong et al., Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand, J INFEC DIS, 181(6), 2000, pp. 1957-1963
Application of dried blood spot specimens for serologic subtyping of humanimmunodeficiency virus type 1 in Thailand
Authors: Chanbancherd, P Brown, AE Trichavaroj, R Tienamporn, P Puthakird, P Limpairojn, N VanCott, TC De Souza, MS
Citation: P. Chanbancherd et al., Application of dried blood spot specimens for serologic subtyping of humanimmunodeficiency virus type 1 in Thailand, J CLIN MICR, 37(3), 1999, pp. 804-806
Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope
Authors: VanCott, TC Mascola, JR Loomis-Price, LD Sinangil, F Zitomersky, N McNeil, J Robb, ML Birx, DL Barnett, S
Citation: Tc. Vancott et al., Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope, J VIROLOGY, 73(6), 1999, pp. 4640-4650
Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
Authors: Mascola, JR Lewis, MG Stiegler, G Harris, D VanCott, TC Hayes, D Louder, MK Brown, CR Sapan, CV Frankel, SS Lu, YC Robb, ML Katinger, H Birx, DL
Citation: Jr. Mascola et al., Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J VIROLOGY, 73(5), 1999, pp. 4009-4018
Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV
Authors: Zolla-Pazner, S Gorny, MK Nyambi, PN VanCott, TC Nadas, A
Citation: S. Zolla-pazner et al., Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV, J VIROLOGY, 73(5), 1999, pp. 4042-4051
Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus
Authors: Lewis, MG Yalley-Ogunro, J Greenhouse, JJ Brennan, TP Jiang, JB VanCott, TC Lu, JC Eddy, GA Birx, DL
Citation: Mg. Lewis et al., Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus, J VIROLOGY, 73(2), 1999, pp. 1262-1270
CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection
Authors: Williams, SB Flanigan, TP Artenstein, AW VanCott, TC Smith, D Mayer, K Koup, RA
Citation: Sb. Williams et al., CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection, J INFEC DIS, 179(5), 1999, pp. 1310-1312
Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type I highly exposed, persistently seronegative female sex workers in northern Thailand
Authors: Beyrer, C Artenstein, AW Rugpao, S Stephens, H VanCott, TC Robb, ML Rinkaew, M Birx, DL Khamboonruang, C Zimmerman, PA Nelson, KE Natpratan, C
Citation: C. Beyrer et al., Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type I highly exposed, persistently seronegative female sex workers in northern Thailand, J INFEC DIS, 179(1), 1999, pp. 59-67
Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion
Authors: Brodine, SK Shaffer, RA Starkey, MJ Tasker, SA Gilcrest, JL Louder, MK Barile, A VanCott, TC Vahey, MT McCutchan, FE Birx, DL Richman, DD Mascola, JR
Citation: Sk. Brodine et al., Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion, ANN INT MED, 131(7), 1999, pp. 502
Analysis of antibody interactions with HIV-1 envelope expressed on the surface of acutely infected H9 cells
Authors: VanCott, TC Hallberg, PL
Citation: Tc. Vancott et Pl. Hallberg, Analysis of antibody interactions with HIV-1 envelope expressed on the surface of acutely infected H9 cells, METH MOL M, 17, 1999, pp. 265-271
Analysis of antibody-antigen interactions using surface plasmon resonance
Authors: VanCott, TC
Citation: Tc. Vancott, Analysis of antibody-antigen interactions using surface plasmon resonance, METH MOL M, 17, 1999, pp. 273-282
Measurement of HIV-1 specific and total antibody secreting cells by ELISPOT
Authors: van Ginkel, FW VanCott, JL Kaminski, R VanCott, TC
Citation: Fw. Van Ginkel et al., Measurement of HIV-1 specific and total antibody secreting cells by ELISPOT, METH MOL M, 17, 1999, pp. 283-292
Collection and processing of mucosal secretions from HIV-1 infected women
Authors: Artenstein, AW VanCott, TC
Citation: Aw. Artenstein et Tc. Vancott, Collection and processing of mucosal secretions from HIV-1 infected women, METH MOL M, 17, 1999, pp. 323-327
Collection and processing of mucosal secretions from mice
Authors: Kaminski, RW VanCott, TC
Citation: Rw. Kaminski et Tc. Vancott, Collection and processing of mucosal secretions from mice, METH MOL M, 17, 1999, pp. 329-339
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children
Authors: Lambert, JS McNamara, J Katz, SL Fenton, T Kang, MH VanCott, TC Livingston, R Hawkins, E Moye, J Borkowsky, W Johnson, D Yogev, S Duliege, AM Francis, L Gershon, A Wara, D Martin, N Levin, F McSherry, F Smith, G
Citation: Js. Lambert et al., Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children, J ACQ IMM D, 19(5), 1998, pp. 451-461
Risultati: 1-20 |